Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/additional-positive-data-from-pivotal-aspen-study-of-brensocatib-in-patients-with-bronchiectasis-to-be-presented-at-the-7th-world-bronchiectasis-conference-302188927.html
https://www.prnewswire.com/news-releases/insmed-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-302164851.html
https://www.prnewswire.com/news-releases/insmed-to-host-commercial-webinar-on-june-4-2024-302159700.html
https://www.prnewswire.com/news-releases/insmed-announces-pricing-of-650-million-public-offering-of-common-stock-302159328.html
https://www.biopharmadive.com/news/insmed-aspen-brensocatib-bronchiectasis-trial-results/717222/
https://www.prnewswire.com/news-releases/insmed-announces-proposed-500-million-public-offering-of-common-stock-302157240.html
https://www.prnewswire.com/news-releases/insmed-announces-positive-topline-results-from-landmark-aspen-study-of-brensocatib-in-patients-with-bronchiectasis-302156279.html
https://www.prnewswire.com/news-releases/insmed-presents-positive-patient-reported-outcomes-and-microbiologic-data-from-phase-3-arise-study-of-arikayce-amikacin-liposome-inhalation-suspension-in-patients-with-ntm-lung-disease-caused-by-mac-at-american-thoracic-society-302150522.html
https://www.prnewswire.com/news-releases/insmed-reports-first-quarter-2024-financial-results-and-provides-business-update-302140525.html
https://investor.insmed.com/2024-04-25-Insmed-to-Host-First-Quarter-2024-Financial-Results-Conference-Call-on-Thursday,-May-9,-2024